TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search results
The World Health Organization said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after new data and studies showed no benefit.
The Trump administration aims to narrow its financial support to about seven experimental coronavirus vaccines from the 14 it has been working with so far, the US Department of Health and Human Services (HHS) said on Tuesday.
The report on Tuesday of a powerful treatment for the new coronavirus brought skepticism along with optimism among US doctors, who said the recent withdrawal of an influential COVID-19 study left them wanting to see more data.
Britain will start giving seriously ill coronavirus patients a basic steroid treatment hailed as a breakthough to help reduce the global pandemic's death toll even as worrying new outbreaks surfaced in China and elsewhere.
Scientists at Imperial College London will start the first clinical trials of a potential COVID-19 vaccine this week with more than 45 million pounds ($56.50 million) in backing from the UK government and philanthropic donors.
The US Food and Drug Administration on Monday revoked its emergency use authorization for hydroxychloroquine to treat COVID-19, but quickly came under fire from President Donald Trump, who said only US agencies have failed to grasp its benefit in fighting the coronavirus.
